Evidence map›Paper›PMID 24210330›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2013

Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.

R A Hanisch, P S Sow, M Toure, A Dem, B Dembele, P Toure, R L Winer, J P Hughes, G S Gottlieb, Q Feng and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Human Papillomavirus infection in senegalese female sex workers.Papillomavirus research (Amsterdam, Netherlands) · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

R A HanischDepartment of Epidemiology, School of Public Health, University of Washington, Box 357236, Seattle, WA 98195, USA; International Agency for Research on Cancer, Section of Environment and Radiation, 150 Cours Albert Thomas, Lyon, 69372 Cedex 08, France. Electronic address: hanischr@fellows.iarc.fr.
P S Sow
M Toure
A Dem
B Dembele
P Toure
R L Winer
J P Hughes
G S Gottlieb
Q Feng
N B Kiviat
S E Hawes
University of Washington-Dakar HIV and Cervical Cancer Study Group
Cheikh Anta Diop University · SNUniversity of Washington · USHarborview Medical Center · USCancer Research And Biostatistics · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart · 1988 to 2026
$104.9M
Antiretroviral Therapy for HIV-2 Infection in SenegalR01AI060466 · NIAID · UNIVERSITY OF WASHINGTON · PI GOTTLIEB, GEOFFREY SCOTT · 2005 to 2014
$6.5M
Developing New Approaches for Cervical Cancer ControlR01CA097275 · NCI · UNIVERSITY OF WASHINGTON · PI KIVIAT, NANCY B. · 2002 to 2006
$2.7M
HIV Associated DNA Hypermethylation in Cervical CancerR01CA111187 · NCI · UNIVERSITY OF WASHINGTON · PI KIVIAT, NANCY B. · 2005 to 2009
$2.6M
CONTROL OF HIV-1 BY HIV-2 ASSOCIATED IMMUNE RESPONSESR01AI048470 · NIAID · UNIVERSITY OF WASHINGTON · PI KIVIAT, NANCY B. · 2000 to 2004
$2.6M
Chlamydia & Aberrant DNA Methylation in Cervical CancerR01CA115713 · NCI · UNIVERSITY OF WASHINGTON · PI KIVIAT, NANCY B. · 2006 to 2010
$2.5M
NCI NIH HHS CA097275NCI NIH HHS CA111187NCI NIH HHS CA 115713NCI NIH HHS R01 CA097275NCI NIH HHS R01 CA111187NCI NIH HHS R01 CA115713NIAID NIH HHS AI48470NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI048470NIAID NIH HHS R01 AI060466
6 · The paper itself

Abstract

backgroundHIV infection is associated with greater risk of precancerous lesions and cervical cancer in women. However, several factors remain unclarified regarding the association between HIV infection and HPV detection, especially among those with HIV type 2 versus type 1 infection and severely immunocompromised persons.

objectivesTo evaluate HPV overall and type-specific detection among HIV-infected and uninfected women in Senegal. STUDY

designDetection of HPV DNA for 38 genotypes in cervical swabs using PCR-based methods was evaluated in HIV-positive (n=467) and HIV-negative (n=2139) women participating in studies in Senegal. Among HIV-1 and/or HIV-2 positive women, CD4 counts were assessed. Adjusted multivariable prevalence ratios (PR) were calculated.

resultsThe prevalence of any HPV DNA and multiple HPV types was greater among HIV-infected individuals (78.2% and 62.3%, respectively) compared with HIV-negative women (27.1% and 11.6%). This trend was also seen for HPV types 16 and 18 (13.1% and 10.9%) compared to HIV-negative women (2.2% and 1.7%). HIV-infected women with CD4 cell counts less than 200 cells/μl had a higher likelihood of any HPV detection (PRa 1.30; 95% CI 1.07-1.59), multiple HPV types (PRa 1.52; 95% CI 1.14-2.01), and HPV-16 (PRa 9.00; 95% CI 1.66-48.67), but not HPV-18 (PRa 1.20, 95% CI 0.45-3.24) compared to those with CD4 counts 500 cells/μl or above.

conclusionHIV-infected women, especially those most severely immunocompromised, are more likely to harbor HPV. Measures to prevent initial HPV infection and subsequent development of cervical cancer through focused screening efforts should be implemented in these high risk populations.

Indexed as

AdolescentAdultAgedAged, 80 and overCD4 Lymphocyte CountCervix UteriCross-Sectional StudiesDNA, ViralFemaleHIV-1HIV-2HIV InfectionsHumansMiddle AgedPapillomaviridaePapillomavirus InfectionsDNA, ViralantiretroviralARVCD4 countcervical intraepithelial neoplasiaCINdeoxyribonucleic acidDNAhigh-risk human papillomavirusHIVHPVHR-HPVhuman immunodeficiency virusHuman immunodeficiency virushuman papillomavirusHuman papillomavirusSenegal

Identifiers

PMID24210330
PMCPMC4059498
OpenAlexW2055660375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.